Volume 100 Number 11
Published online 26 May 2009 (1697 - 1836)
---------------------------------------------------------------------
What if you could gain a clear view of the genomic aberrations that
matter?
Agilent SurePrint G3 CGH/CNV microarrays are designed from the largest
database of probes spanning all regions of the genome including complex
regions, and offer the flexibility to incorporate user-defined CNVs. Use
DNA microarrays from Agilent, and start mapping the variants that count.
Learn more at
http://links.ealert.nature.com/ctt?kn=17&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
---------------------------------------------------------------------
British Journal of Cancer publishes high quality original papers and
reviews that make a significant contribution to increasing understanding
of the causes of cancer and to improving the treatment and survival of
patients.
Visit the journal online at
http://links.ealert.nature.com/ctt?kn=7&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
to view the latest research and access selected articles FREE of charge.
---------------------------------------------------------------------
British Journal of Cancer has an impact factor 4.635*
*2007 Journal Citation Report (Thomson Reuters, 2008)
----------------------
MINIREVIEW
----------------------
T-regulatory cell modulation: the future of cancer immunotherapy[quest]
S Nizar, J Copier, B Meyer, M Bodman-Smith, C Galustian, D Kumar and A Dalgleish
Abstract: http://links.ealert.nature.com/ctt?kn=65&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=66&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
----------------------
REVIEWS
----------------------
Treatment in advanced colorectal cancer: what, when and how[quest]
I Chau and D Cunningham
Abstract: http://links.ealert.nature.com/ctt?kn=42&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=54&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
----------------------
CLINICAL STUDIES
----------------------
A multicenter phase II study of the combination of oxaliplatin, irinotecan
and capecitabine in the first-line treatment of metastatic colorectal
cancer
E Vasile, G Masi, L Fornaro, S Cupini, F Loupakis, S Bursi, I Petrini,
S Di Donato, I M Brunetti, S Ricci, A Antonuzzo, S Chiara, D Amoroso,
M Andreuccetti and A Falcone
Abstract: http://links.ealert.nature.com/ctt?kn=49&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=43&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
A phase II trial of preoperative chemotherapy with epirubicin, cisplatin
and capecitabine for patients with localised gastro-oesophageal junctional
adenocarcinoma
N Starling, A Okines, D Cunningham, W Allum, A Wotherspoon, M Benson,
J Thompson, J Thomas, G Brown, A Riddell, F Stavridi, S Ashley, J Oates
and I Chau
Abstract: http://links.ealert.nature.com/ctt?kn=21&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=79&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Clinical management of borderline tumours of the ovary: results of a
multicentre survey of 323 clinics in Germany
A Coumbos, J Sehouli, R Chekerov, D Schaedel, G Oskay-Oezcelik, W
Lichtenegger and W Kuehn
Abstract: http://links.ealert.nature.com/ctt?kn=73&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=14&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
FDG uptake is a surrogate marker for defining the optimal biological dose
of the mTOR inhibitor everolimus in vivo
D Cejka, C Kuntner, M Preusser, M Fritzer-Szekeres, B J Fueger, S Strommer,
J Werzowa, T Fuereder, T Wanek, M Zsebedics, M Mueller, O Langer and V Wacheck
Abstract: http://links.ealert.nature.com/ctt?kn=45&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=13&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant
murine model
S Julien, G Picco, R Sewell, A-S Vercoutter-Edouart, M Tarp, D Miles, H
Clausen, J Taylor-Papadimitriou and J M Burchell
Abstract: http://links.ealert.nature.com/ctt?kn=52&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=6&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism
B Cambien, B F Karimdjee, P Richard-Fiardo, H Bziouech, R Barthel, M A
Millet, V Martini, D Birnbaum, J Y Scoazec, J Abello, T Al Saati, M G
Johnson, T J Sullivan, J C Medina, T L Collins, A Schmid-Alliana and H
Schmid-Antomarchi
Abstract: http://links.ealert.nature.com/ctt?kn=60&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=86&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
----------------------
MOLECULAR DIAGNOSTICS
----------------------
Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common
disease processes with hepatocellular carcinoma
C H Lee, C J Chang, Y J Lin, C N Yeh, M F Chen and S Y Hsieh
Abstract: http://links.ealert.nature.com/ctt?kn=30&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=25&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Diagnostic precision of image-guided multisampling core needle biopsy of
suspected lymphomas in a primary care hospital
P Loubeyre, T A McKee, M Copercini, A Rosset and P-Y Dietrich
Abstract: http://links.ealert.nature.com/ctt?kn=71&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=35&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Correlation of RET somatic mutations with clinicopathological features
in sporadic medullary thyroid carcinomas
M M Moura, B M Cavaco, A E Pinto, R Domingues, J R Santos, M O Cid, M J
Bugalho and V Leite
Abstract: http://links.ealert.nature.com/ctt?kn=27&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=44&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Elevated level of inhibin-[alpha] subunit is pro-tumourigenic and pro-
metastatic and associated with extracapsular spread in advanced prostate
cancer
P Balanathan, E D Williams, H Wang, J S Pedersen, L G Horvath, M G Achen,
S A Stacker and G P Risbridger
Abstract: http://links.ealert.nature.com/ctt?kn=40&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=32&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
----------------------
EPIDEMIOLOGY
----------------------
Insulin-like growth factor levels in cord blood, birth weight and breast
cancer risk
P Lagiou, C C Hsieh, L Lipworth, E Samoli, W Okulicz, R Troisi, B Xu,
P Hall, A Ekbom, H O Adami and D Trichopoulos
Abstract: http://links.ealert.nature.com/ctt?kn=53&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=61&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
A prospective Swedish study on body size, body composition, diabetes,
and prostate cancer risk
P Wallstrom, A Bjartell, B Gullberg, H Olsson and E Wirfalt
Abstract: http://links.ealert.nature.com/ctt?kn=22&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=2&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Prevalent cases in observational studies of cancer survival: do they
bias hazard ratio estimates[quest]
E M Azzato, D Greenberg, M Shah, F Blows, K E Driver, N E Caporaso and
P D P Pharoah
Abstract: http://links.ealert.nature.com/ctt?kn=23&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=5&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Dietary isoflavone and the risk of colorectal adenoma: a case-control
study in Japan
M Akhter, M Iwasaki, T Yamaji, S Sasazuki and S Tsugane
Abstract: http://links.ealert.nature.com/ctt?kn=57&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=29&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Plasma phyto-oestrogens and prostate cancer in the European Prospective
Investigation into Cancer and Nutrition
R C Travis, E A Spencer, N E Allen, P N Appleby, A W Roddam, K Overvad,
N F Johnsen, A Olsen, R Kaaks, J Linseisen, H Boeing, U Nothlings, H B
Bueno-de-Mesquita, M M Ros, C Sacerdote, D Palli, R Tumino, F Berrino, A
Trichopoulou, V Dilis, D Trichopoulos, M-D Chirlaque, E Ardanaz, N
Larranaga, C Gonzalez, L R Suarez, M-J Sanchez, S Bingham, K-T Khaw,
G Hallmans, P Stattin, S Rinaldi, N Slimani, M Jenab, E Riboli and T J Key
Abstract: http://links.ealert.nature.com/ctt?kn=48&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=62&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a
British cohort
I dos Santos Silva, P A Wark, V A McCormack, D Mayer, C Overton, V Little,
J Nieto, P Hardiman, M Davies and A B MacLean
Abstract: http://links.ealert.nature.com/ctt?kn=50&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=11&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Risk of cervical abnormality after age 50 in women with previously negative
smears
R G Blanks, S M Moss, S Addou, D A Coleman and A J Swerdlow
Abstract: http://links.ealert.nature.com/ctt?kn=19&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=87&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
---------------------------------------------------------------------
Ensure your access to British Journal of Cancer
If you are unable to access the articles in this Table of Contents e-alert,
your library may not subscribe to this journal. Our online recommendation
form is a simple way to make your librarian aware that this journal is
valuable to your research.
Recommend now at
http://links.ealert.nature.com/ctt?kn=64&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=28&m=33342651&r=MTc2MDAwMTgxNgS2&b=2&j=NTA3NDExMTES1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
